Quantitation of MHC antigen expression on colorectal tumours and its association with tumour progression
Open Access
- 1 December 1987
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 56 (4) , 425-432
- https://doi.org/10.1038/bjc.1987.218
Abstract
A flow cytometric technique has been established for accurately quantitating the cell surface density of MHC antigens and the percentage of cells expressing MHC antigens in 38 colorectal tumours. Thirty-four percent of tumours were partially or completely negative for HLA-ABC antigen expression. Although the quantity of HLA-ABC antigens varied widely, there was no correlation between the density of HLA-ABC antigens, or the percentage of cells expressing these antigens and clinicopathological stage. Fifty percent of the colorectal tumours expressed HLA-DR with varying antigen densities. All of the poorly differentiated tumours expressed HLA-DR but there was no correlation between expression of HLA-DR and clinicopathological stage. The aneuploid tumours expressed more HLA-ABC and HLA-DR antigens on a higher percentage of cells than the diploid tumours. Abnormal expression of the tumour associated antigens CEA, Y haptenic blood group and 791T p72 also correlated with expression of HLA-ABC and HLA-DR antigens on colorectal tumours. The majority of early derived in vitro dividing cells failed to express both HLA-ABC and HLA-DR antigens although they expressed high levels of tumour associated antigens. If there is a correlation between in vitro and in vivo growth perhaps tumours are maintained and seeded by MHC antigen negative cells.Keywords
This publication has 30 references indexed in Scilit:
- T-cell responses at the host: tumour interfaceBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1986
- Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategyNature, 1986
- Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism.The Journal of Experimental Medicine, 1985
- Abrogation of metastatic properties of tumour cells by de novo expression of H–2K antigens following H–2 gene transfectionNature, 1985
- Kinetics of divalent monoclonal antibody binding to tumour cell surface antigens using flow cytometry: Standardization and mathematical analysisMolecular Immunology, 1985
- Rejection of transplantable AKR leukaemia cells following MHC DNA-mediated cell transformationNature, 1984
- The membrane antigens of human colorectal cancer cells: Demonstration with monoclonal antibodies of heterogeneity within and between tumours and of anomalous expression of HLA-DREuropean Journal of Cancer and Clinical Oncology, 1983
- Characteristics of a cell surface antigen defined by an anti-human osteogenic sarcoma monoclonal antibodyEuropean Journal of Cancer and Clinical Oncology, 1983
- Expression of DR Antigens in Freshly Frozen Human TumorsHybridoma, 1982
- Specificity of antigen binding by T cells; competition between soluble and Ia‐associated antigenEuropean Journal of Immunology, 1981